Skip to main content
  • Home
  • Topics
    • Topic 1 - Anatomy and Physiology
    • Topic 2 - Assessment and common lung diseases
    • Topic 3 - Treatment
    • Topic 4 - Management
  • About RESPe
  • How to use this site
  • Links and resources
  • Contact

Common examples of dry powder inhalers

Ellipta inhaler

Ellipta®

Umeclidinium - Long acting muscarinic antagonist (LAMA) Incruse Ellpita®

Umeclidinium plus vilanterol – LAMA + LABA. Anoro Ellipta®

Budesonide + formoterol. ICS + LABA Symbicort Turbohaler®

‹ Dry Powder Inhalers up How to help your patient get the most out of inhalers ›
  • Topic 1 - Anatomy and Physiology
  • Topic 2 - Assessment and common lung diseases
  • Topic 3 - Treatment
    • Medication
    • Inhalers
      • Benefits of inhalers
      • Advantages and disadvantages for inhalers
      • Metered Dose Inhalers (MDI)
      • MDI technique
      • Why is inhaler technique so important?
      • Spacer devices
      • Breath Activated Aerosol Inhalers
      • Respimat Inhaler
      • Dry Powder Inhalers
      • Common examples of dry powder inhalers
      • How to help your patient get the most out of inhalers
    • Nebulisers
    • Oxygen therapy
    • Non-pharmacological treatments
  • Topic 4 - Management
Sitemap Contact us Login (admin only)
Disclaimer Accessibility Privacy policy

Copyright © 2018-2025 Chest Heart & Stroke Scotland and The University of Edinburgh. Some rights reserved. Site published by the Interactive Content Team, Information Services, The University of Edinburgh

CHSS Logo
NES Logo
NHS Logo
University of Edinburgh Logo
Scotish Goverment Logo